Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies

There is a growing need to better understand the risk of malignancy in the multiple sclerosis (MS) population, particularly given the relatively recent and widespread introduction of immunomodulating disease modifying therapies (DMTs). Multiple sclerosis disproportionately affects women, and the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Bridge, Francesca, Brotherton, Julia M. L., Foong, Yi, Butzkueven, Helmut, Jokubaitis, Vilija G., Van der Walt, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950275/
https://www.ncbi.nlm.nih.gov/pubmed/36846149
http://dx.doi.org/10.3389/fneur.2023.1119660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950275/
https://www.ncbi.nlm.nih.gov/pubmed/36846149
http://dx.doi.org/10.3389/fneur.2023.1119660

Ejemplares similares